Company Overview
About Kernal Biologics
Kernal Biologics is a clinical-stage biotech developing AI-designed mRNA therapeutics for cancer and autoimmune diseases — using machine learning to engineer cell-type-specific mRNA sequences that direct therapeutic payloads (including CAR-T gene programs) to the right cells in vivo, enabling off-the-shelf CAR-T cancer therapy without the individualized cell extraction and ex vivo manufacturing process that makes current CAR-T treatments cost $400,000+ and require weeks of production time. The Y Combinator-backed company has raised $35.8 million including a $25 million Series A led by Hummingbird Ventures with participation from Amgen Ventures.
Business Model & Competitive Advantage
Kernal's platform analyzes transcriptome data to identify cell-type-specific RNA regulatory elements — promoters, UTRs, and expression signals that direct which cell types will take up and express a given mRNA. By engineering these regulatory elements using ML-guided design, Kernal can create mRNA constructs that preferentially express in specific cell populations (T cells, B cells, macrophages) after systemic delivery, enabling CAR-T programs to work without ex vivo cell collection. The lead program KR-335 is advancing toward IND filing for immuno-oncology indication.
Competitive Landscape 2025–2026
In 2025, Kernal competes in the mRNA therapeutics and cell therapy market with Moderna, BioNTech, and In Vivo Therapeutics for next-generation mRNA platforms, and with Beam Therapeutics, Prime Medicine, and other ex vivo CAR-T developers for the oncology and autoimmune indication space. The promise of in vivo CAR-T — delivering a gene therapy injection that programs the patient's own immune cells to fight cancer — represents a potential transformation of a $20B+ CAR-T market by eliminating the manufacturing complexity. Amgen Ventures' participation signals pharma interest in next-generation cell therapy platforms. The 2025 strategy focuses on advancing KR-335 toward clinical trials, building the mRNA design platform evidence base, and exploring partnership opportunities with larger biopharma companies for CAR-T and autoimmune indications.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Kernal Biologics is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
CoverMyMeds
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Compare Kernal Biologics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Kernal Biologics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Kernal Biologics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Kernal Biologics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →